All Stories

  1. Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial

    Article • PLoS ONE, July 2022, PLOS

    MD, Ph.D Jeong JH Heo

  2. Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)

    Article • OncoImmunology, June 2019, Taylor & Francis

    MD, Ph.D Jeong JH Heo, Caroline Breitbach, Philippe MERLE

  3. Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection

    Article • Hepatology Communications, April 2018, Wiley

    Associate Professor Tawesak Tanwandee, MD, Ph.D Jeong JH Heo

  4. Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1

    Article • Journal of Gastroenterology and Hepatology, November 2017, Wiley

    MD, Ph.D Jeong JH Heo, Professor MING-LUNG YU

  5. Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens

    Article • Liver International, October 2017, Wiley

    MD, Ph.D Jeong JH Heo

  6. Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study

    Article • OncoImmunology, May 2017, Taylor & Francis

    MD, Ph.D Jeong JH Heo, Professor Yong-Soo Bae

  7. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma

    Article • Mediators of Inflammation, January 2017, Hindawi Publishing Corporation

    MD, Ph.D Jeong JH Heo, Dr So Young Yoo, Mr Badrinath Narayanasamy

  8. Viruses as nanomedicine for cancer

    Article • International Journal of Nanomedicine, September 2016, Dove Medical Press

    Dr So Young Yoo, Mr Badrinath Narayanasamy, MD, Ph.D Jeong JH Heo

  9. Effect of yttrium-90 radioembolization on outcomes in Asian patients with early to advanced stage hepatocellular carcinoma

    Article • Hepatology Research, August 2016, Wiley

    MD, Ph.D Jeong JH Heo

  10. A 96-week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy

    Article • Journal of Gastroenterology and Hepatology, April 2016, Wiley

    MD, Ph.D Jeong JH Heo